<DOC>
	<DOC>NCT01367587</DOC>
	<brief_summary>This study evaluates the safety of multiple doses of IV MNTX in normal healthy adults.</brief_summary>
	<brief_title>Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone</brief_title>
	<detailed_description />
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1. Must be male or nonpregnant female volunteers 2. Must be 18 to 65 yrs of age 3. Must have no significant active disease states 1. History or current evidence of disease (cardiovascular, respiratory, endocrine, renal, hepatic, hematological, or psychiatric) 2. Illicit drug users 3. Subjects who received an experimental new drug in the past 30 days 4. Subjects with any laboratory findings outside normal limits</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>